CYCCyclopharm
About Cyclopharm
Cyclopharm (ASX:CYC) is a nuclear medicine company that develops, manufactures, and markets radiopharmaceuticals for the diagnosis and treatment of disease. The company’s flagship product is Technegas, which is a radiopharmaceutical used for functional lung ventilation imaging.
What is CYC known for?
Snapshot
Public AU
Ownership
1986
Year founded
10
Employees
New South Wales, Australia
Head office
1 of 19
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Australia
Products and/or services of Cyclopharm
- Technegas: A radiopharmaceutical used for functional lung ventilation imaging.
- Research and development: Cyclopharm is actively engaged in research and development, with a focus on developing new radiopharmaceuticals for the diagnosis and treatment of pulmonary diseases.
Cyclopharm executive team
- Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO, MD, Company Secretary & Director
- Mr. Jason SmithChief Financial Officer
- Mr. Mathew FaragChief Operating Officer
- Ms. Sally-Ann CorneliusHead of Sales
- Ms. Niamh McAreeHead of Quality and Regulatory
- Mr. Chris QuinnHead of Service
- Ms. Sui Ling CheahFinancial Controller
- Mr. Lynn McLauchlinGeneral Manager of Canada
- Mr. Gary T. SomervilleQuality & Regulatory Manager